bought juno last friday at 27.05 after -39% haircut
sold juno on tuesday AH at 35 (not quite catch top price 36.50)
today just re-entered juno at 28.37 and now stock rallying to 28.90 in huge buy volume
gotta love this yo-yo juno game and juno will be gung ho tomorrow again in the green
from Tuesday after hours high 36.50 back down to 28.25 today = gotta hop back in again for second trip up north = gotta love this yo-yo in-and-out game to pocket green cash $$$
stock still runs up to make a new high at 42.39 = ouch for me
don't know what the strength behind the stock today - a revelation yesterday of a hedge fund owning a large holding of twlo? Humm
will probably be back on august 8 to scoop up shares at deep on sale price after hopefully a "bad" earning report via ER loss = we shall see ...
bailed out of twlo holding at 41.80 within first 15 minutes of trading day leaning on green strength = from 33+ to 41+ is one heck of green profit $$$ = merci bien
i will come back to scoop up shares again at market melt-down within a couple weeks = until then ciao with a pocket full of green cash $$$
yabba dabba doo to juno and fda hold removal = green $$$
=== Shares of Juno Therapeutics soared in extended trading after the biopharmaceutical company announced that the FDA removed the clinical hold on a cancer drug trial. The trial, dubbed the "ROCKET" trial, focuses on adult patients with relapsed or refractory B cell acute lymphoblastic leukemia.
very good strategy and you are rewarded handsomely AH today 7/12 on your heavy juno bet
no "losing sleep" over the weekend, eh? now u can go out and have that special drink to celebrate
too bad i was away from my computer AH and did not catch 36.50 top price but sold 2/3 holding at 35 for cash
huge green profit +26% gain for merely 3-day hold since entry point on friday 7/8 = gotta love small cap biotech
stock went back below your selling price 21.20 and now AH at 20.80
already won my bet on rlyp today and AH is juno bet to cash in $$$
juno is gung ho AH today Tuesday 7/12 for +29% leap due to FDA removing hold
sold 2/3 of holding AH to pocket huge green profits = will let 1/3 run tomorrow $$$
regn is under pressure today due to amgen got approval for is drug Repatha ....
=== This approval could help give Amgen's Repatha a clinical leg up over its primary PSCK9 inhibitor competitor, Praluent, which is marketed by Regeneron Pharmaceuticals (NASDAQ:REGN) and Sanofi (NYSE:SNY). Praluent is currently approved to be administered by injection once every two weeks, so offering patients a more convenient dosing option could help give Amgen an edge.